Difficulty: Medium
Average Score: 66%
Practice
Your lab group has been evaluating the effects of 'Ultron' a new drug for the treatment of intractable hiccups. When administered over a wide concentration range, three dose-response relationships were defined in test subjects. Using facial flushing as an unwanted side effect, what would be the estimated therapeutic index for Ultron?
Correct answer
C
Rationale
In pharmacology, the therapeutic index (TI) is a crucial concept that helps determine the safety and efficacy of a drug. The TI is calculated by dividing the median lethal dose (LD50) by the median effective dose (ED50). A higher TI indicates a safer drug as it means the effective dose is much lower than the toxic dose.
In this scenario, the estimated therapeutic index for Ultron can be calculated based on its dose-response relationships. Since the therapeutic index is the ratio of the dose that produces toxicity (facial flushing in this case) to the dose that provides therapeutic effect, a larger therapeutic index indicates a safer drug.
Option C (10) is the correct answer because it suggests that there is a tenfold difference between the dose that causes facial flushing (toxicity) and the dose that is therapeutically effective. This indicates a relatively safe drug profile.
Option A (0.1) is incorrect because a therapeutic index less than 1 would indicate that the drug is more toxic than effective, making it unsafe for use.
Option B (100) is incorrect because a therapeutic index of 100 would suggest a very wide safety margin, which is unlikely in this case given the side effect of facial flushing.
Option D (Can't determine) is incorrect as the information provided allows for the calculation of the estimated therapeutic index based on the defined dose-response relationships.
Understanding the concept of therapeutic index is essential for healthcare professionals to make informed decisions regarding drug safety and efficacy when treating patients. It highlights the importance of balancing therapeutic benefits with potential side effects to ensure patient well-being.
In this scenario, the estimated therapeutic index for Ultron can be calculated based on its dose-response relationships. Since the therapeutic index is the ratio of the dose that produces toxicity (facial flushing in this case) to the dose that provides therapeutic effect, a larger therapeutic index indicates a safer drug.
Option C (10) is the correct answer because it suggests that there is a tenfold difference between the dose that causes facial flushing (toxicity) and the dose that is therapeutically effective. This indicates a relatively safe drug profile.
Option A (0.1) is incorrect because a therapeutic index less than 1 would indicate that the drug is more toxic than effective, making it unsafe for use.
Option B (100) is incorrect because a therapeutic index of 100 would suggest a very wide safety margin, which is unlikely in this case given the side effect of facial flushing.
Option D (Can't determine) is incorrect as the information provided allows for the calculation of the estimated therapeutic index based on the defined dose-response relationships.
Understanding the concept of therapeutic index is essential for healthcare professionals to make informed decisions regarding drug safety and efficacy when treating patients. It highlights the importance of balancing therapeutic benefits with potential side effects to ensure patient well-being.